Precision Medicine Thursdays at Venture Café
Attendance is FREE and open to all.
Speakers
Hong Chen, PhD
Assistant Professor of Radiation Oncology Washington University in St. Louis
“Noninvasive molecular diagnosis of brain cancer by sonobiopsy”
Blood-based liquid biopsy is a promising noninvasive diagnostic technique to acquire a comprehensive molecular tumor profile by detecting cancer-specific biomarkers (e.g., DNA, RNA, and protein). However, there has been limited progress for brain tumor applications partially because of the blood-brain barrier (BBB), which hinders the release of brain tumor biomarkers. To address this unmet need, we developed sonobiopsy technique, which uses focused ultrasound to increase the BBB permeability and thus enhance the release of brain tumor-specific biomarkers into the bloodstream for the noninvasive molecular diagnosis of brain tumors by blood tests.
Aadel Chaudhuri, MD PhD
Assistant Professor of Radiation Oncology Washington University in St. Louis
“SurgiSeq: A Novel Liquid Biopsy Platform for Minimal Residual Disease Detection after Surgery”
SurgiSeq, an innovative approach to liquid biopsy analysis after cancer surgery for minimal residual disease detection.
On the third Thursday of every month, ICTS Precision Medicine hosts a session featuring WashU faculty working in translational genomics/precision medicine areas. Talks are typically oriented toward biotechnology, diagnostics, informatics, start-ups and precision interventions based on medical genomics innovations.